State-Supported Cannabis Dispensary Financing Is Not Preempted by the CSA Absent an Actual Conflict

Case: Cannabis Impact Prevention Coalition, LLC v New York State Cannabis Control Bd., 2026 NY Slip Op 06364

Court: Appellate Division, Supreme Court of New York, Third Department
Decided: October 29, 2026
Opinion: Mackey, J.; unanimous concurrence

1. Introduction

This decision addresses whether federal prohibition of marijuana prevents New York from financing the development of state-licensed cannabis dispensaries. The Third Department held that the challenged financing framework was not preempted by the federal Controlled Substances Act (CSA). Although the financing facilitates a market in marijuana, it neither requires anyone to violate federal law nor prevents federal authorities from enforcing that law.

The plaintiffs—Cannabis Impact Prevention Coalition, LLC, other organizations, and individual taxpayers—challenged expenditures supporting conditional adult-use cannabis retail dispensaries, known as CAURDs. They sought a permanent injunction against the use of state funds for dispensary capital and related costs, together with a declaration that those expenditures violated the CSA and other federal laws.

The defendants included New York’s Cannabis Control Board (CCB), Office of Cannabis Management (OCM), relevant state officials, the Dormitory Authority of the State of New York (DASNY), the New York Social Equity Cannabis Investment Fund (the Fund), and DASNY’s subsidiary, the Social Equity Servicing Corporation (SESC).

The decision’s central contribution is its application of an existing conflict-preemption analysis to affirmative financial support for cannabis businesses. The court rejected the proposition that state assistance to a federally prohibited industry necessarily creates a preemptive conflict.

2. Statutory Background and Procedural History

The federal and state frameworks

As described in the opinion, marijuana remained a Schedule I controlled substance under federal law. Subject to limited exceptions, the CSA prohibits its knowing or intentional manufacture, distribution, dispensing, and possession.

New York nevertheless enacted the Marihuana Regulation and Taxation Act (MRTA) in March 2021, creating the Cannabis Law and legalizing adult-use marijuana under state law. The CCB was assigned rulemaking responsibilities, while OCM was charged with regulating the cannabis marketplace.

The financing arrangements relevant to this litigation developed through several statutory provisions:

  • State Finance Law § 99-ii (2): Established the state cannabis revenue fund to receive cannabis-related taxes and other legally transferred money.
  • State Finance Law § 99-ii (3) (d) and Public Authorities Law § 1678 (32): Authorized DASNY to select a private debt or equity fund to finance capital and related costs associated with establishing CAURDs. The Fund was selected for that purpose.
  • Public Authorities Law § 1678 (30) and (31): Provided the framework under which DASNY and SESC used financing supplied through the Fund to obtain premises and undertake design, construction, and improvement work for dispensaries.

The taxpayer action

Plaintiffs sued under State Finance Law § 123-b, challenging the use of state funds to establish and outfit dispensaries operated by social-equity licensees. Their principal theory was that these expenditures supported activities prohibited by federal law.

Defendants moved to dismiss, arguing lack of standing, untimeliness, laches, and failure to state a cause of action. Supreme Court concluded that plaintiffs had standing and that the action was not time-barred, but dismissed the complaint because the challenged expenditures did not conflict with the CSA and were not federally preempted.

The Third Department affirmed the February 21, 2025 judgment, without costs. Because dismissal was proper on the merits of the preemption issue, defendants’ alternative arguments supporting affirmance became academic. The appellate decision therefore should not be treated as an independent endorsement of Supreme Court’s conclusions on standing or timeliness.

3. Summary of the Opinion

Plaintiffs argued that the CSA’s prohibition of marijuana cultivation, manufacture, distribution, and possession preempted MRTA and its associated financing arrangements. In their view, using state funds to facilitate dispensary development directly conflicted with Congress’s objectives.

The court rejected that argument by applying its earlier decision concerning New York’s cannabis labeling, advertising, and marketing regulations. It identified several reasons why the financing framework did not create the conflict necessary for preemption:

  • It did not require any person to manufacture, distribute, or possess marijuana.
  • It did not grant immunity from federal law.
  • It did not impair federal authorities’ ability to prosecute marijuana-related offenses.
  • MRTA preserved federal law’s applicability and pursued regulatory objectives that included reducing illicit trafficking and protecting public health and safety.

The court acknowledged that the financing scheme was designed to facilitate licensed marijuana distribution. That connection, however, did not establish either physical impossibility of complying with federal law or actual obstruction of federal law. Plaintiffs’ remaining contentions were rejected without separate substantive discussion.

4. Analysis

A. Precedents Cited

Gonzales v Raich, 545 US 1 (2005)

The court cited Gonzales v Raich when describing the federal prohibition governing marijuana. Its role was to establish the federal-law backdrop: state legalization does not eliminate the CSA’s application.

The present decision does not question federal authority to prohibit marijuana. Instead, it addresses the distinct question whether that federal prohibition displaces New York’s financing legislation. Keeping those questions separate is essential: conduct can remain federally unlawful even though a state statute relating to that conduct survives a preemption challenge.

American Catalog Mailers Assn. v Department of Taxation & Fin., 249 AD3d 1298 (3d Dept 2026)

This precedent supplied the general preemption framework. Federal law can displace state law through express preemption, occupation of an entire regulatory field, or conflict between federal and state requirements.

Its importance here was organizational. It situated the dispute within Supremacy Clause doctrine and distinguished conflict preemption—the theory actually analyzed—from the other routes to displacement of state law.

Matter of Quigley v Village of E. Aurora, 193 AD3d 207 (3d Dept 2021), leave denied 37 NY3d 908 (2021)

The court cited this decision as additional authority for the general preemption framework. The opinion did not discuss its underlying facts or draw a specific factual analogy. Its contribution was doctrinal support for the categories of preemption, rather than a cannabis-specific rule.

Sutton 58 Assoc. LLC v Pilevsky, 36 NY3d 297 (2020), certiorari dismissed, 142 S Ct 53 (2021)

This Court of Appeals decision supported the governing conflict-preemption test. A conflict may exist where compliance with both federal and state law is physically impossible, or where state law obstructs the accomplishment of Congress’s purposes and objectives.

That distinction matters because the absence of compelled federal illegality does not, by itself, answer every preemption question. A law might avoid contradictory commands yet still obstruct federal objectives. The Third Department therefore considered both the absence of mandatory prohibited conduct and the financing scheme’s effect on federal enforcement.

Matter of Cannabis Impact Prevention Coalition, LLC v Hochul, 252 AD3d 235 (3d Dept 2026)

This was the controlling analogy and the opinion’s principal substantive authority. In that earlier case, the Third Department considered regulations governing the labeling, advertising, and marketing of medical and adult-use marijuana. It concluded that those regulations neither made compliance with federal law impossible nor obstructed Congress’s purposes under the CSA.

The earlier decision characterized the asserted conflicts as “merely hypothetical or potential conflicts.” Neither MRTA nor the challenged regulations required anyone to manufacture, distribute, or possess marijuana. MRTA also preserved federal law’s applicability and regulated the market in pursuit of public-health and anti-trafficking objectives.

The present case extended that reasoning to financing. Plaintiffs emphasized that New York was not merely regulating private conduct but affirmatively supporting dispensary development. The court nevertheless found the same analysis controlling: financial support did not compel prohibited conduct, create federal immunity, or obstruct federal prosecution.

This extension is the decision’s most significant precedential development. The court declined to treat the distinction between regulatory supervision and financial assistance as sufficient, without more, to establish conflict preemption.

Matter of Buenos Hill Inc. v Saratoga Springs Planning Bd., 240 AD3d 990 (3d Dept 2025), appeal dismissed 44 NY3d 1015 (2025)

The court relied on this precedent for contextual support concerning federal tolerance of state-authorized marijuana activity. It quoted the earlier decision’s observation that many states permit medical or recreational marijuana and that federal enforcement policy has accommodated state-authorized use, including through restrictions on certain federal prosecution expenditures.

This consideration bolstered the court’s conclusion; it did not replace the conflict-preemption analysis. The opinion did not examine the precise scope of the referenced funding restrictions. Its discussion should not be read as recognizing a general federal exemption for recreational marijuana or as converting enforcement restraint into repeal of the CSA.

B. Legal Reasoning

1. State authorization is distinct from federal permission

The decision rests on a distinction between changing state law and changing federal law. New York’s authorization and support of cannabis businesses do not make their federally prohibited activities lawful under the CSA. Equally, the continued existence of federal prohibition does not automatically invalidate every state measure concerning cannabis.

The relevant inquiry was therefore not simply whether the supported dispensaries would distribute a federally prohibited substance. It was whether the challenged state framework produced the kind of legal conflict that requires displacement under the Supremacy Clause.

2. The financing scheme did not make dual compliance impossible

The court found no state-imposed obligation to manufacture, distribute, or possess marijuana. The financing arrangement made dispensary development possible or easier, but did not command anyone to engage in prohibited activity.

For purposes of impossibility preemption, that distinction was decisive. The state framework did not place an individual or entity under incompatible legal commands requiring and forbidding the same conduct.

3. Facilitating cannabis activity was not itself sufficient obstruction

The more substantial question concerned obstacle preemption. Plaintiffs argued that public support for dispensaries frustrated the CSA’s prohibition of marijuana distribution, even without a mandatory state command.

The court expressly acknowledged the financing program’s facilitative purpose. It nevertheless required an actual obstruction of federal law, not merely a policy inconsistency between state legalization and federal prohibition.

Several features supported its conclusion: federal law remained applicable, the scheme provided no immunity, federal prosecution remained available, and MRTA pursued regulatory objectives such as reducing illicit trafficking and protecting health and safety. Taken together, these considerations prevented plaintiffs from establishing the asserted conflict.

4. Preserving enforcement was central

The opinion repeatedly emphasized that federal authorities remained free to enforce the CSA. New York’s financing arrangements did not prevent investigation or prosecution of the manufacture, possession, or distribution of marijuana.

The resulting distinction is practical and important: a state may support an industry under its own law without guaranteeing that participation is lawful under federal law. Surviving preemption does not eliminate participants’ federal exposure.

5. The holding has defined limits

The decision upheld dismissal of the particular challenge to the financing framework. It did not declare that every provision of MRTA, every cannabis subsidy, or every activity undertaken by a funded dispensary is beyond federal challenge.

Nor did it independently analyze whether particular transactions satisfy the elements of a federal offense. Although plaintiffs invoked other federal laws and raised additional contentions, the opinion supplied substantive reasoning principally on CSA conflict preemption. Its summary rejection of remaining arguments does not establish a detailed rule for federal issues it did not separately discuss.

C. Potential Impact

Greater protection for state cannabis financing frameworks

The decision provides significant support for New York’s challenged dispensary-financing structure. It also gives future courts a reason to reject the categorical argument that affirmative financial assistance necessarily creates a greater preemptive conflict than licensing or regulation.

A more demanding showing for future challengers

Future plaintiffs will need to identify more than the fact that state policy facilitates conduct prohibited by the CSA. Under this reasoning, they must demonstrate incompatible legal obligations or an actual obstruction of federal purposes or enforcement.

A materially different statute or implementation could present another question—for example, one involving mandatory prohibited conduct or interference with federal enforcement. The court did not decide such circumstances.

No resolution of the underlying federal-state divide

The ruling preserves the coexistence of state-authorized cannabis markets and continuing federal prohibition. It reduces a particular threat to New York’s financing arrangements without harmonizing the two legal systems or removing the federal risks faced by market participants.

Limited procedural significance

Although the litigation proceeded as a taxpayer challenge under State Finance Law § 123-b, the appellate holding concerns the substantive preemption theory. Because the alternative grounds for affirmance were academic, the decision offers limited appellate guidance on standing, limitations, or laches.

5. Complex Concepts Simplified

Supremacy Clause
The constitutional rule that valid federal law prevails over conflicting state law. The question is whether a legally sufficient conflict exists, not merely whether federal and state policies differ.
Express preemption
Congress explicitly states that specified state laws are displaced.
Field preemption
Federal regulation is so comprehensive that it leaves no room for state regulation in the relevant field.
Conflict preemption
State law is displaced because complying with both legal systems is impossible or because state law obstructs federal objectives.
Impossibility preemption
A person cannot obey both laws at once. Here, the state financing scheme did not require anyone to engage in marijuana activity prohibited by federal law.
Obstacle preemption
Even without contradictory commands, state law may be displaced if it obstructs Congress’s purposes. The court found that supporting dispensary development did not establish the necessary obstruction in this case.
State legalization versus federal immunity
State legalization removes or changes state-law prohibitions. Federal immunity would protect conduct from federal enforcement. The opinion recognized the former, not the latter.
Laches
A defense based on unreasonable delay that prejudices another party. The appellate court did not need to resolve this defense.
Academic alternative arguments
Arguments the court need not decide because another ground already resolves the appeal.

6. Conclusion

The Third Department held that New York’s challenged financing of cannabis dispensary development was not preempted merely because it facilitated an industry prohibited by federal law. The controlling considerations were the absence of compelled federal illegality, the continued applicability of the CSA, and the preservation of federal enforcement authority.

The opinion extends earlier cannabis-regulation precedent to affirmative financial assistance. Its significance is substantial but bounded: it protects the challenged state financing framework from this conflict-preemption attack without legalizing marijuana federally or immunizing participants from federal prosecution.

This commentary addresses the supplied opinion, which is designated uncorrected and subject to revision before publication in the Official Reports.